Portfolio Co Investors 2026 for SV Health Investors: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
SV Health Investors accounts for 23 tracked companies with verified cap-table data, 23 of which disclose round sizes totalling $3.1B. The median disclosed raise is $95M, and the largest is AdvanCell at $440M, ahead of Bardy Diagnostics ($375M) and Quell Therapeutics ($344M).
The names that recur most often on these co-invested cap tables are SV Health Investors (23 companies), Bain Capital Life Sciences (3 companies), Jeito Capital (3 companies), Omega Funds (3 companies), Johnson & Johnson Innovation (3 companies), Sofinnova Partners (3 companies). By latest disclosed round, the market skews Series B (8), Series A (7), Series C (4), Series D (2).
Companies tracked: 23
Disclosed funding total: $3.1B across 23 companies
Median disclosed raise: $95M
Largest raise: AdvanCell — $440M
Stage mix: Series B 8 · Series A 7 · Series C 4 · Series D 2
